Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab

Total article views   HTML views PDF downloads Totals
9,935 Dovepress* 8,235+ 1,489 9,724
PubMed Central* 1,700 519 2,219
Totals 9,935 2,008 11,943
*Since 22 August 2018
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed Central and Google Scholar